Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Lancet

Volumn 362, Issue 9386, 2003, Pages 755-757

  White, Harvey D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; PLACEBO; RAMIPRIL;

ANTIHYPERTENSIVE ACTIVITY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG USE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; NOTE; PATIENT; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0042831479     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14295-X     Document Type: Note

References (5)

1. Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 355:2000;1575-1581.
2. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published erratum appears in N Engl J Med 2000; 342: 748]. N Engl J Med 2000; 342: 145-53.
3. Yusuf S., Pepine C.J., Garces C., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 340:1992;1173-1178.
4. Myocardial infarction redefine - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J. 21:2000;1502-1513.
5. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease: Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 335:1990;765-774.